<p>Use of a toxin which specifically inhibits cellular protein synthesis for the manufacture of a pharmaceutical composition for the treatment of acquired immunodeficiency syndrome (AIDS). The pharmaceutical composition comprises a liposomal preparation containing said toxin.</p>
